Innovative Strategies to Enhance the Bioavailability of Cannabidiol: Nanotechnology and Advanced Delivery Systems
Pharmaceuticals · 29.10.2025 · 18 (11) · 1637
DOI: 10.3390/ph18111637 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 29.10.2025. Verfasst von Magdalena Paczkowska-Walendowska und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacognosy and Biomaterials, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Poznan, Poland. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Center.
Abstract (Originalsprache)
Cannabidiol (CBD), a phytocannabinoid with therapeutic potential for neurological and other conditions, faces significant challenges in bioavailability due to its low water solubility, high lipophilicity, and extensive first-pass metabolism. Researchers have developed advanced nanodelivery systems addressing these limitations to enhance CBD’s absorption, stability, and efficacy. This review provides not only a comprehensive summary of current nanotechnological delivery strategies for CBD, including nanoemulsions, liposomes, polymeric micelles, nanosuspensions, and cyclodextrin inclusion complexes, but also introduces a distinct comparative and integrative perspective. Unlike previous reviews, our work synthesizes preclinical and clinical evidence while highlighting the novel integration of nanotechnology with bioenhancers and personalized medicine approaches. We further emphasize the emerging concepts of hybrid and smart nanocarriers, which have not yet been systematically discussed, positioning them as next-generation solutions to overcome CBD’s bioavailability challenges and paving the way for precision therapeutics.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacognosy and Biomaterials, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Poznan, Poland.
- Department of Pharmacology and Phytochemistry, Institute of Natural Fibres and Medicinal Plants-National Research Institute, Kolejowa 2, 62-064 Plewiska, Poland.
- Chair of Brewing and Beverage Technology, TUM School of Life Sciences, Technical University of Munich, 85354 Freising, Germany.
- Department of Urology and Urological Oncology, Pomeranian Medical University, Powstańców Wlkp. 72, 70-111 Szczecin, Poland.
- Department of Vascular, Endovascular Surgery, Angiology and Phlebology, Poznan University of Medical Science, Dluga 1/2, 61-848 Poznan, Poland.
ORCID-Profile: Magdalena Paczkowska-Walendowska, Aleksandra Dziopa, Arash Moeini, Zbigniew Krasiński, Judyta Cielecka-Piontek
Förderung
- National Science Center
Zitieren
APA
Paczkowska-Walendowska, M., Trzaskoma, P., Dziopa, A., Moeini, A., Soczawa, M., Krasiński, Z., & Cielecka-Piontek, J. (2025). Innovative Strategies to Enhance the Bioavailability of Cannabidiol: Nanotechnology and Advanced Delivery Systems. Pharmaceuticals, 18(11), 1637. https://doi.org/10.3390/ph18111637
Vancouver
Paczkowska-Walendowska M, Trzaskoma P, Dziopa A, Moeini A, Soczawa M, Krasiński Z, et al. Innovative Strategies to Enhance the Bioavailability of Cannabidiol: Nanotechnology and Advanced Delivery Systems. Pharmaceuticals. 2025;18(11):1637. doi:10.3390/ph18111637
BibTeX
@article{PaczkowskaWalendowska2025,
author = {Paczkowska-Walendowska, Magdalena and Trzaskoma, Piotr and Dziopa, Aleksandra and Moeini, Arash and Soczawa, Michał and Krasiński, Zbigniew and Cielecka-Piontek, Judyta},
title = {Innovative Strategies to Enhance the Bioavailability of Cannabidiol: Nanotechnology and Advanced Delivery Systems},
journal = {Pharmaceuticals},
year = {2025},
volume = {18},
number = {11},
pages = {1637},
doi = {10.3390/ph18111637}
}
EUVIMED